Pfizer Buys Arena For $6.7bn In Bid To Diversify In Inflammation & Immunology

S1P Asset Will Add To JAK-Heavy Pipeline

 
• By Jessica Merrill
  
Wallet
Pfizer is ready to spend on deals • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business